Halozyme Therapeutics | HALO - PE Price to Earnings

Stock Price
63.58
Daily Change
-0.07 -0.11%
Monthly
-10.43%
Yearly
-1.15%
Q1 Forecast
61.74

Halozyme Therapeutics reported 23.16 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin 91.05 88.3 Jun/2023
Amgen 25.31 15.82 Dec/2025
Baxter International 17.1 4.46 Sep/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics 23.16 7.7 Dec/2025
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
MannKind 303.7 273.14 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
United Therapeutics 17.32 1.62 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023